# Investigation on the Epidemic Prevention Effect of Using Chinese Medicine During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak.

> **NCT05236309** · — · COMPLETED · sponsor: **Taipei City Hospital** · enrollment: 2000 (actual)

## Conditions studied

- COVID-19 Pandemic

## Interventions

- **DRUG:** Jing-Guan-Fang(JGF) : Chinese herbal decoction

## Key facts

- **NCT ID:** NCT05236309
- **Lead sponsor:** Taipei City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-11-18
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05236309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05236309, "Investigation on the Epidemic Prevention Effect of Using Chinese Medicine During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05236309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*